Clinical Trial Update: GTB-5550 in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GTB-5550 in advanced solid tumors. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• GTB-5550

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Tri-specific Killer Engager, Solid Tumor | Phase 1 | Status: RECRUITING